Beam Therapeutics Inc. (BEAM) vs TransMedics Group, Inc. (TMDX)
A side-by-side comparison of Beam Therapeutics Inc. and TransMedics Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
BEAM
Beam Therapeutics Inc.
$24.47HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
TMDX
TransMedics Group, Inc.
$79.33HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
Total return — BEAM vs TMDX
growth of $100 · dividends reinvested · last 7yBEAM +30.1% (+3.8%/yr)TMDX +341.3% (+23.6%/yr)TMDX compounded faster over this window
BEAM TMDX
BEAM vs TMDX: by the numbers
- •TMDX is the larger company ($2.74B vs $2.52B market cap).
- •TMDX is profitable (22.69% net margin) while BEAM runs a net loss (-54.75%).
- •BEAM grew revenue faster over the past five years (479.04% vs 86.12% CAGR).
Metrics side by side
Valuation
| Metric | BEAM | TMDX |
|---|---|---|
| P/E ratio | N/A | 20.55 |
| Forward P/E | N/A | 54.08 |
| P/S ratio | 16.13 | 4.10 |
| P/B ratio | 2.36 | 5.29 |
| EV / EBITDA | N/A | 26.57 |
| FCF yield | N/A | 2.88% |
Profitability
| Metric | BEAM | TMDX |
|---|---|---|
| Gross margin | 84.05% | 58.69% |
| Operating margin | -274.57% | 12.21% |
| Net margin | -54.75% | 22.69% |
| ROE | -8.00% | 29.28% |
| ROIC | -28.96% | 5.87% |
Growth (annualized)
| Metric | BEAM | TMDX |
|---|---|---|
| Revenue CAGR (5Y) | 479.04% | 86.12% |
| Total return CAGR (5Y) | -22.35% | 19.20% |
Frequently asked
- Which has grown faster, BEAM or TMDX?
- Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus TMDX at 86.12%.
- Is BEAM or TMDX more profitable?
- TMDX runs the higher net margin — BEAM at -54.75% versus TMDX at 22.69%.
- How have BEAM and TMDX total returns compared?
- Over the past 5 years, BEAM delivered -22.35% and TMDX delivered 19.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TransMedics P/E ratioBeam Therapeutics ROETransMedics ROEBeam Therapeutics operating marginTransMedics operating marginBeam Therapeutics revenue growthTransMedics revenue growthBeam Therapeutics free cash flowTransMedics free cash flow
Beam Therapeutics & TransMedics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.